Paraneoplastic syndrome
PCFor patient information, click here
Paraneoplastic syndrome Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2]
Synonyms and keywords: Paraneoplastic syndrome
Overview
Paraneoplastic syndromes are a rare type of disease that is caused by abnormal immune systems resulting from cancerous cells. Paraneoplastic syndromes are disorders due to the release of hormones, or peptides that cause immune cross-reactivity between cancerous cells and normal tissues. Sometimes the symptoms of paraneoplastic syndromes show even before the diagnosis of a malignancy. There is no screening for paraneoplastic syndromes. The stage and type of diagnosis of cancer determine the prognosis of a paraneoplastic syndrome. The causes are mostly related to the organ affected. The paraneoplastic syndromes are divided into four main categories such as musculocutaneous, neurological, hematological and endocrines. They are no cures for the paraneoplastic syndrome, but cancer treatment and some medications to reduce autoimmune responses are helpful.
Classification
- Paraneoplastic syndromes may be classified into 5 main categories accordingly:
- Endocrine metabolic syndromes:
- Hypercalcemia in breast cancer and lung cancer (typically squamous cell) due to the production of PTHrP (Parathyroid hormone-related protein)
- Seen also in multiple myeloma, renal cell carcinoma, ovarian cancer, endometrial cancer, and lymphoma
- SIADH
- Associated cancers: small cell lung cancer, mesothelioma, breast, prostate, adrenal, urethral, thymoma, lymphoma, GI, CNS, and Ewing sarcoma
- Ectopic ACTH secretion associated with small-cell lung cancer, carcinoid tumor, thymoma and other cancers
- Tumor induced osteomalacia
- Hypoglycemia
- Associated cancers: GI, mesothelioma, lung, and sarcomas
- Hypercalcemia in breast cancer and lung cancer (typically squamous cell) due to the production of PTHrP (Parathyroid hormone-related protein)
- Musculocutaneous paraneoplastic syndromes
- Dermatomyositis (25-50% of adult patients have an underlying malignancy)
- Leser-Trélat sign, a sudden onset of many pigmented skin lesions.
- Associated cancers: gastrointestinal adenocarcinomas (gastric, colon, rectal), breast cancer, and lymphoproliferative disorders/lymphoma, melanoma, and etc.
- Acanthosis nigricans, seen in gastric adenocarcinoma, endometrial cancer, and etc.
- Necrolytic migratory erythema which may be seen in pancreatic tumor.
- Sweet's syndrome, most commonly associated with acute myeloid leukemia or another hematologic malignancy.
- Pyoderma gangrenosum is associated with Squamous cell carcinoma, cutaneous lymphoma.
- Neurological paraneoplastic syndromes:
- Paraneoplastic cerebellar degeneration associated with lung, ovarian, breast, lymphatic, and other cancers
- Encephalomyelitis (inflammation of the brain and spinal cord)
- Limbic encephalitis
- Brainstem encephalitis
- Opsoclonus (involving eye movement)
- Encephalitis triggered by a teratoma
- Polymyositis
- Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer
- Myasthenia gravis
- Subacute (peripheral) sensory neuropathy
- Autonomic neuropathy
- Hematological paraneoplastic syndromes
- Granulocytosis (increased granulocytes) due to the production of G-CSF
- Eosinophilia
- Pure red cell aplasia
- Thrombocytosis
- Others:
- Endocrine metabolic syndromes:
Causes
Common Causes
- The major causes of paraneoplastic syndrome include:
Causes by Organ System
- Paraneoplastic syndromes causes may be regrouped by organ system.
Dermatologic | |
Ear Nose Throat | |
Endocrine | |
Gastroenterologic |
|
Hematologic | |
Musculoskeletal/Orthopedic | |
Neurologic | |
Obstetric/Gynecologic | |
Oncologic | |
Pulmonary | |
Renal/Electrolyte | |
Rheumatology/Immunology/Allergy |
|
Urologic | |
Miscellaneous |
Differential diagnosis
Paraneoplastic syndromes must be differentiated from others types of cancer depending on the location and type of organs.
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histopathology | |||||||||||||
Small cell lung cancer |
|
_ |
|
_ | Small, round and oval cells | Biopsy | _ | ||||||||
Squamous lung cancer |
|
|
|
|
_ | _ |
|
_ |
|
_ | |||||
Hepatocellular carcinoma |
|
_ | _ | _ |
|
|
_ | ||||||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings |
Breast cancer |
|
|
|
|
_ | _ | _ | _ | _ |
|
_ | ||||
Renal cancer |
|
|
|
_ | _ |
|
_ | ||||||||
Pancreatic cancer |
|
|
_ |
|
_ | ||||||||||
Gastric cancer |
|
_ |
|
_ |
|
_ |
|
| |||||||
Lymphoma | _ |
|
|
_ | _ | _ |
|
_ | |||||||
Ovarian cancer |
|
|
|
|
_ | _ |
|